Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease ; volume:17 ; number:1 ; day:12 ; month:5 ; year:2022 ; pages:1-3 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (12.5.2022), 1-3, 12.2022
- Creator
-
Zhao, Yingjun
Xu, Huaxi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00541-z
- URN
-
urn:nbn:de:101:1-2022071721020254193137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Yingjun
- Xu, Huaxi
- SpringerLink (Online service)
Other Objects (12)
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models